Metabolizing enzyme localization and activities in the first trimester human placenta: The effect of maternal and gestational age, smoking and alcohol consumption

Human Reproduction

Volumn 17, Issue 10, 2002, Pages 2564-2572

  Collier, Abby C ^a,b,c   Tingle, Malcolm D ^a   Paxton, James W ^a   Mitchell, Murray D ^a,b   Keelan, Jeffrey A ^a,b  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

^c UNIVERSITY OF NEVADA   (United States)

Author keywords

Alcohol consumption; CYP1A; Plancental metabolism; Smoking; UDP glucuronosyltransferase

Indexed keywords

BETA GLUCURONIDASE; CHLORZOXAZONE; CYTOCHROME P450 1A; CYTOCHROME P450 2E1; DRUG METABOLIZING ENZYME; ETHOXYRESORUFIN; GLUCURONOSYLTRANSFERASE; GLUCURONOSYLTRANSFERASE 1A; GLUCURONOSYLTRANSFERASE 2B; HYMECROMONE; HYMECROMONE GLUCURONIDE; UNCLASSIFIED DRUG; XENOBIOTIC AGENT;

ADOLESCENT; ADULT; ALCOHOL CONSUMPTION; ARTICLE; CAUCASIAN; CIGARETTE SMOKING; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EXPOSURE; DRUG METABOLISM; ENVIRONMENTAL FACTOR; ENZYME ACTIVITY; ENZYME LOCALIZATION; ETHNIC DIFFERENCE; FEMALE; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MATERNAL AGE; MOTHER; PLACENTA; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SAMPLING; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SYNCYTIUM;

EID: 0036799064     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/17.10.2564     Document Type: Article

References (71)

1. Audus, K.L. (1999) Controlling drug delivery across the placenta. Eur. J. Pharmac. Sci., 8, 161-165.
2. Autti-Ramo, I. and Granstrom, M. (1991) The effect of intrauterine alcohol exposition in various durations on early cognitive development. Neuropaediatrics, 22, 203-210.
3. Bardham, A. (1966) The effect of parity and maternal age on birth weight. J. Nat. Med. Assoc., 58, 194-196.
4. Bar-Oz, B., Moretti, M.E., Maureels, G., Tittelboom, T.V. and Koren G. (1999) Reporting bias in retrospective ascertainment of drug-induced embryopathy. Lancet, 354, 1700-1701.
5. Beresford, A.P. (1993) CYP1A1: friend or foe. Drug. Metab. Rev., 25, 503-517.
6. Bock, K.W., Gschmaidmeier, H., Heel, H., Lehmkoster, T., Munzel, P.A. and Bock-Hennig, B.S. (1999) Functions and transcriptional regulation of PAH-inducible human UDP-glucuronosyltransferases. Drug. Metab. Rev., 31, 411-422.
7. Boyd, R. and Kudo, Y. (1994) Transport functions of the placenta and fetal membranes. In Thorburn, G.D. and Harding, R. (eds), Textbook of Fetal Physiology. Oxford University Press, New York, pp. 6-16.
8. Briggs, G.G., Freeman, R.K. and Yaffe, S.J. (1994) Drugs in Pregnancy and Lactation, 4th edn. Williams and Wilkins, Baltimore, pp. xi-xvii.
9. Burchell, B., Brierly, C.H. and Rance, D. (1995) Specificity of human UDP-glucuronosyltransferases and xenobiotic glucuronidation. Life Sci., 57, 1819-1831.
10. Campbell, M.A. and Fantel, A.G. (1983) Teratogenicity of acetaldehyde in vitro: relevance to the fetal alcohol syndrome. Life Sci., 32, 2641-2647.
11. Chen, F., Ritter, J.K., Wang, M.G., McBride, O.W., Lubert, R.A. and Owens, I.S. (1993) Characterisation of cloned human dihydrotestosterone/androstanediol UDP-glucuronosyltransferase and its comparison with other steroid isoforms. Biochemistry, 32, 10648-10657.
12. Cheng, Z., Radominska-Pandya, A. and Tephly, T.R. (1998) Cloning and expression of human UDP-glucuronosyltransferase (UGT) 1A8. Arch. Biochem. Biophys., 356, 301-305.
13. Cnattingius, S., Forman, M.R., Berendes, H.W., Graubard, B.I. and Isotalo, L. (1993) Effect of age, parity and smoking on pregnancy outcomes: a population-based study. Am. J. Obstet. Gynecol., 168, 16-21.
14. Collier, A.C., Tingle, M.D., Keelan, J.A., Paxton, J.W. and Mitchell, M.D. (2000) A highly sensitive fluorescent microplate method for the determination of UDP-glucuronosyl transferase activity in tissues and placental cell lines. Drug Metab. Dispos., 28, 1184-1186.
15. Collier, A.C., Ganley, N.A., Tingle, M.D., Blumenstein, M., Marvin, K.W., Paxton, J.W., Mitchell, M.D. and Keelan, J.A. (2002) UDP-Glucuronosyltransferase activity, expression and cellular localization in human placenta at term. Biochem. Pharmacol., 63, 409-419.
16. Conney, A.H. (1986) Induction of microsomal cytochrome P-450 enzymes. The first Bernard B. Brodie lecture at Pennsylvania State University. Life. Sci., 39, 2493-2518.
17. Coughtrie, M.W., Burchell, B., Leakey, J.E. and Hume, R. (1988) The inadequacy of perinatal glucuronidation: immunoblot analysis of the developmental expression of individual UDP-glucuronosyltransferase isoenzymes in rat and human liver microsomes. Mol. Pharmacol., 34, 729-735.
18. Delescluse, C., Lemaire, G., Sousa, G.D. and Rahmani, R. (2000) Is CYP1A1 induction always related to AHR signaling pathway? Toxicology, 153, 73-82.
19. Desoye, G., Hofman, H.H. and Weiss, P.A. (1992) Insulin binding to trophoblast plasma membranes and placental glycogen content in well-controlled gestational diabetic women treated with diet or insulin, in well-controlled overt diabetic patients and in healthy control subjects. Diabetologia, 35, 45-55.
20. Dutton, D.R. and Parkinson, A. (1989) Reduction of 7-alkoxyresorufins by NADPH-cytochrome P450 reductase and its differential effects on their O-dealkylation by rat liver microsomal cytochrome P450. Arch. Biochem. Biophys., 268, 617-629.
21. Farin, F.M., Pohlman, T.H. and Omiecinski, C.J. (1994) Expression of cytochrome P450s and microsomal epoxide hydrolase in primary cultures of human umbilical vein endothelial cells. Toxicol. Appl. Pharmacol., 124, 1-9.
22. Fox, H. (1997) Aging of the placenta. Arch. Dis. Childhood, 77, F171-175.
23. Green, M.D., Oturu, E.M. and Tephly, T.R. (1994) Stable expression of a human liver UDP-glucuronosyltransferase (UGT2B15) with activity toward steroid and xenobiotic substrates. Drug. Metab. Dispos, 22, 799-805.
24. Grove, A.D., Llewellyn, G.C., Kessler, F.K., White, K.L., Crespi, C.L. and Ritter, J.K. (2000) Differential protection by rat UDP-glucuronosyltransferase 1A7 against benzo [a]pyrene-3,6-quinone versus benzo[a]pyrene-induced cytotoxic effects in human lymphoblastoid cells. Toxicol. Appl. Pharmacol., 162, 34-43.
25. Hakkola, J., Pasanen, M., Hukkanen, J., Pelkonen, O., Maenpaa, J., Edwards, R.J., Boobis, A.R. and Raunio, H. (1996a) Expression of xenobiotic-metabolising cytochrome P450 Forms in human full term placenta. Biochem. Pharmacol., 51, 403-411.
26. Hakkola, J., Raunio, H., Purkunen, R., Pelkonen, O., Saarikoski, S., Cresteil, T. and Pasanen, M. (1996b) Detection of cytochrome P450 gene expression in human placenta in first trimester of pregnancy. Biochem. Pharmacol., 52, 379-383.
27. Hakkola, J.M., M. Passanen, Pelkonen, O., Hukkanen, J., Visalmi, S., Anttila, S., Rane, A., Mantyla, Purkunen, R., Saarkoski, S., Tooming, M. and Raunio, H. (1997) Expression of CYP1B1 in human adult and fetal tissues and differential inducibility of CYP1B1 and CYP1A1 by Ah receptor ligands in human placenta and cultured cells. Carcinogenesis, 18, 391-397.
28. Hakkola, J., Pelkonen, O., Passanen, M. and Raunio, H. (1998) Xenobiotic-metabolising cytochrome P450 enzymes in the human feto-placental unit: role in intrauterine toxicity. Crit. Rev. Toxicol., 28, 35-72.
29. Hoffman, J.H., Welte, J.W. and Barnes, G.M. (2001) Co-occurrence of alcohol and cigarette use among adolescents. Addict. Behav., 26, 63-78.
30. Hu, Y., Hakkola, J., Oscarson, J. and Ingleman-Sundberg, M. (1999) Structural and functional characterisation of the 5′-flanking region of the rat and human cytochrome P450 2E1 genes: identification of a polymorphic repeat in the human gene. Biochem. Biophys. Res. Commun., 263, 286-293.
31. Jin, C.-J., Miners, J.O., Lillywhite, K.J. and Mackenzie, P.I. (1992) Complementary deoxyribonucleic acid cloning and expression of a human liver uridine diphosphate glucuronosyl transferase glucuronidating carboxylic acid-containing drugs. J. Pharmacol. Exp. Ther., 264, 475-479.
32. Jin, C.-J., Miners, J.O., Lillywhite, K.J. and Mackenzie, P.I. (1993) cDNA cloning and expression of two new members of the human liver UDP-glucuronosyltransferase 2B subfamily. Biochem. Biophys. Res. Commun., 194, 496-503.
33. Jones, K.L. and Smith, D.W. (1973) Recognition of the fetal alcohol syndrome in early infancy. Lancet, 2, 999-1001.
34. Kane, S.H. (1967) Advancing age and the primigravida. Obstet. Gynecol., 29, 409-414.
35. Kardon, T., Coffey, M.J., Banhegyi, G., Conley, A.A., Burchell, B., Mandl, J. and Braun, L. (2000) Transcriptional induction of bilirubin UDP-glucuronosyltransferase by ethanol in the rat liver. Alcohol, 21, 251-257.
36. Kari, F.W., Kauffman, F.C. and Thurman, R.G. (1985) Effect of bile salts on rates of formation, accumulation and export of mutagenic metabolites from benzo(a)pyrene produced by the perfused rat liver. Cancer Res., 45, 1621-1627.
37. Klaassen, C.D. (1996) Biotransformation of Xenobiotics. In Cassaret and Doull (eds) Toxicology, 5th edn, McGraw-Hill, New York.
38. Kono, H., Bradford, B., Yin, M., Sulik, K., Koop, D., Peters, J., Gonzalez, F., McDonald, T., Dikalova, A., Kadiiska, M., Mason, R. and Thurman, R. (1999) CYP2E1 is not involved in early alcohol-induced liver injury. Am. J. Physiol., 277, G1259-G1267.
39. Koop, DR. and Tierney, D.J. (1990) Multiple mechanisms in the regulation of ethanol-inducible cytochrome P450IIE1. Bioessays, 12, 429-435.
40. Lechevrel, M. and Wild, C.P. (1997) Absence of a differential induction of cytochrome P450 2E1 by different alcoholic beverages in rats: implications for the etiology of human osophageal cancer. Arch. Toxicol., 71, 690-695.
41. Lewis, D.F. (2000) On the recognition of mammalian microsomal P450 substrates and their characteristics. Biochem. Pharmacol., 60, 293-306.
42. Li, YQ., Prentice, D.A., Howard, M.L., Mashford, ML., Wilson, J.S. and Desmond, P.V. (1999) Alcohol up-regulates UDP-glucuronosyltransferase mRNA expression in rat liver and in primary rat hepatocyte cultures. Life Sci., 66, 575-584.
43. Litterst, C.L., Mimnaugh, E.G., Regan, R.L. and Gram, T.E. (1975) Comparison of in vitro drug metabolism by lung, liver and kidney in common laboratory species. Drug Metab. Dispos., 3, 259-265.
44. Lucas, D., Menez, Z.-F. and Berthou, F. (1996) Chlorzoxazone: an in vitro and in vivo substrate probe for liver CYP2E1. Meth. Enzymol., 272, 115-123.
45. Ma, J., Betts, N. and Hampl, J. (2000) Clustering of lifestyle behaviors: the relationship between cigarette smoking, alcohol consumption, and dietary intake. Am. J. Health. Prom., 15, 107-117.
46. Mackenzie, P., Owens, I., Burchell, B., Bock, K., Bairoch, A., Belanger, A., Fournel-Gigleux, S., Green, M., Hum, D., Iyanagi, T, et al. (1997) The UDP glycosyltransferase gene superfamily: recommended nomenclature update based on evolutionary divergence. Pharmacogenetics, 7, 255-269.
47. McRobie, D.J., Glover, D.D. and Tracy, T.S. (1998) Effects of gestational and overt diabetes on human placental cytochromes P450 and glutathione S-transferase. Drug Metab. Dispos., 26, 367-371.
48. Miners, J.O., Boase, S., Bowalgaha, K. and Mackenzie, P.I. (2000) In vitro-in vivo extrapolation of kinetic data for drugs eliminated by glucuronidation in humans. Proc. Australasian Soc. Clin. Exp. Pharmacol. Toxicol., 8, 42.
49. Moore, M.L. and Zaccaro, D.J. (2000) Cigarette smoking, low birthweight and pre-term births in low-income African American women. J. Perinatol., 20, 176-180.
50. Morgan, D.J. (1997) Drug disposition in mother and foetus. Clin. Exp. Pharmacol. Physiol., 24, 869-873.
51. Onishi, S., Kawade, N., Itoh, S., Isobe, K. and Sugiyama, S. (1979) Postnatal development of uridine diphosphate glucuronyltransferase activity towards bilirubin and 2-aminophenol in human liver. Biochem. J., 184, 705-707.
52. Pasanen, M., Vahakangas, K., Sotanemi, E.A. and Pelkonen, O. (1986) The effect of cigarette smoking on drug metabolism in the liver and placenta: the use of cotinine in verifying smoking status. Eur. J. Drug. Metab. Pharmacokinet., 13, 41-45.
53. Pelkonen, O. (1984) Xenobiotic metabolism in the materno-placental-fetal unit: implications for fetal toxicity. Dev. Pharmacol. Ther., 7, 11-17.
54. Pirani, B.B. and MacGillivray, I. (1978) Smoking during pregnancy. Its effect on maternal metabolism and fetoplacental function. Obstet. Gynecol., 52, 257-263.
55. Rasheed, A., Hines, R.N. and Carver-May, D.G. (1997) Variation in induction of human placental CYP2E1: possible role in susceptibility to fetal alcohol syndrome. Toxicol. Appl. Pharmacol., 144, 396-400.
56. Ritter, J.K., Sheen, Y.Y. and Owens, I.S. (1990) Cloning and expression of a human liver UDP-glucuronosyltransferase glucuronidating carboxylic acid-containing drugs. J. Biol. Chem., 265, 7900-7906.
57. Sastry, B.V.R. (1991) Placental toxicology: tobacco smoke, abused drugs, multiple chemical interactions and placental function. Reprod. Fertil. Dev., 3, 355-372.
58. Sesardic, D., Pasanen, M., Pelkonen, O. and Boobis, A. (1990) Differential expression and regulation of members of the cytochrome P450IA gene subfamily in human tissues. Carcinogenesis, 11, 1183-1188.
59. Sigler, A.T., Lilienfeld, A.M., Cohen, B.H. and Westlake, J.E. (1965) Parental age in Down's syndrome (mongolism). J. Pediat., 67, 631-642.
60. Smith, P.K., Krohn, R.I., Hermanson, G.T., Mallia, A.K., Gartner, F.H., Provenzano, M.D., Fujimoto, E.K., Olson, B.J. and Klenk, D.C. (1985) Measurement of protein using bicinchoninic acid. Analyt. Biochem., 150, 76-85.
61. Song, B., Veech, R. and Saenger, P. (1990) Cytochrome P4502E1 is elevated in lymphocytes from poorly controlled insulin-dependent diabetics. J. Clin. Endocrinol. Metab., 71, 1036-1040.
62. Sperker, R., Backman, J.T. and Kroemer, H.K. (1997) The role of β-glucuronidase in drug disposition and drug targeting in humans. Clin. Pharmacokinet., 33, 18-31.
63. Stoilov, I., Jansson, I., Sarfazi, M. and Schenkman, J.B. (2001) Roles of cytochrome P450 in development. Drug Metab. Drug Interact., 18, 33-55.
64. Strassburg, C.P., Manns, M.P. and Tukey, R.H. (2001) Expression of the UDP-glucuronosyltransferase 1A locus in the human colon. J. Biol. Chem., 273, 8719-8726.
65. Terelius, Y., Norsten-Hoog, C., Cronholm, T. and Ingelman-Sundberg, M. (1991) Acetaldehyde as a substrate for ethanol-induced cytochrome P450 (CYP2E1). Biochem. Biophys. Res. Commun., 179, 689-694.
66. Tiribelli, C. and Ostrow, J.D. (1996) New Concepts in Bilirubin and Jaundice: Report of the Third International Bilirubin Workshop, April 6-8, 1995, Trieste, Italy. Hepatology, 24, 1926-1311.
67. Trubetskoy, O.V. and Shaw, P.M. (1999) A fluorescent assay amenable to measuring production of β-D-glucuronides produced from recombinant UDP-glycosyl transferase enzymes. Drug Metab. Dispos., 27, 555-557.
68. Tukey, R.H. and Strassburg, C.P. (2000) Human UDP-glucuronosyltransferase: metabolism, expression and disease. Annu. Rev. Pharmacol. Toxicol., 40, 581-618.
69. Weinans, M., Pratt, J., Wolf, B.D. and Mantingh, A. (2001) First-trimester maternal serum human thyroid-stimulating hormone in chromosomally normal and Down syndrome pregnancies. Prenatal Diag., 21, 723-725.
70. Whyatt, R.M., Bell, D.A., Jedrychowski, W., Santella, R.M., Garte, S.J., Cosma, G., Manchester, D.K., Young, T.L., Cooper, T.B., Ottman, R. and Perera, F.P. (1998) Polycyclic aromatic hydrocarbon-DNA adducts in human placenta and modulation by CYP1A1 induction and genotype. Carcinogenesis, 19, 1389-1392.
71. Yueh, M.F., Nguyen, N., Famourzadeh, M., Strassburg, C.P., Oda, Y., Gugenrich, F.P. and Tukey, R.H. (2001) The contribution of UDP-glucuronosyltransferase 1A9 on CYP1A2-mediated genotoxicity by aromatic and heterocyclic amines. Carcinogenesis, 22, 943-950.